
Global IVIG Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global IVIG market size will reach Million USD in 2025 and is projected to reach Million USD by 2032, with a CAGR of % (2025-2032). Notably, the China IVIG market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Intravenous immunoglobulin (IVIG) is a medical treatment that involves the intravenous infusion of concentrated immunoglobulins, which are antibodies derived from pooled plasma of thousands of blood donors. Immunoglobulins are proteins that play a key role in the immune system's defense against infections. IVIG is used as a therapeutic intervention in various medical conditions, including autoimmune disorders, primary immunodeficiencies, and certain neurological conditions. The infusion of IVIG provides a boost to the immune system, helping to modulate and regulate immune responses. It is often prescribed to individuals with compromised immune function or those experiencing abnormal immune activity. IVIG therapy is administered in a clinical setting, and the dosage and frequency of infusions depend on the specific medical condition being treated. The use of IVIG has shown efficacy in managing a range of immune-related disorders, making it a valuable tool in medical practice.
The major global manufacturers of IVIG include Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, LFB Group, BPL, Sichuan Yuanda Shuyang, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of IVIG. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global IVIG market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the IVIG market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of IVIG industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of IVIG Include:
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
IVIG Product Segment Include:
IVIg Liquid
IVIg Powder
IVIG Product Application Include:
Immunodeficiency
Autoimmune Disease
Acute Infection
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global IVIG Industry PESTEL Analysis
Chapter 3: Global IVIG Industry Porter's Five Forces Analysis
Chapter 4: Global IVIG Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global IVIG Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global IVIG Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, IVIG Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global IVIG market size will reach Million USD in 2025 and is projected to reach Million USD by 2032, with a CAGR of % (2025-2032). Notably, the China IVIG market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Intravenous immunoglobulin (IVIG) is a medical treatment that involves the intravenous infusion of concentrated immunoglobulins, which are antibodies derived from pooled plasma of thousands of blood donors. Immunoglobulins are proteins that play a key role in the immune system's defense against infections. IVIG is used as a therapeutic intervention in various medical conditions, including autoimmune disorders, primary immunodeficiencies, and certain neurological conditions. The infusion of IVIG provides a boost to the immune system, helping to modulate and regulate immune responses. It is often prescribed to individuals with compromised immune function or those experiencing abnormal immune activity. IVIG therapy is administered in a clinical setting, and the dosage and frequency of infusions depend on the specific medical condition being treated. The use of IVIG has shown efficacy in managing a range of immune-related disorders, making it a valuable tool in medical practice.
The major global manufacturers of IVIG include Baxter, Grifols, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, CBPO, LFB Group, BPL, Sichuan Yuanda Shuyang, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of IVIG. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global IVIG market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the IVIG market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of IVIG industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of IVIG Include:
Baxter
Grifols
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
IVIG Product Segment Include:
IVIg Liquid
IVIg Powder
IVIG Product Application Include:
Immunodeficiency
Autoimmune Disease
Acute Infection
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global IVIG Industry PESTEL Analysis
Chapter 3: Global IVIG Industry Porter's Five Forces Analysis
Chapter 4: Global IVIG Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global IVIG Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global IVIG Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, IVIG Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 IVIG Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 IVIG Product by Type
- 1.2.1 IVIg Liquid
- 1.2.2 IVIg Powder
- 1.3 IVIG Product by Application
- 1.3.1 Immunodeficiency
- 1.3.2 Autoimmune Disease
- 1.3.3 Acute Infection
- 1.4 Global IVIG Market Revenue and Sales Analysis
- 1.4.1 Global IVIG Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global IVIG Sales Market Size Analysis (2020-2032)
- 1.4.3 Global IVIG Market Sales Price Trend Analysis (2020-2032)
- 1.5 IVIG Market Development Status and Trends
- 1.5.1 IVIG Industry Development Status Analysis
- 1.5.2 IVIG Industry Development Trends Analysis
- 2 IVIG Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 IVIG Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global IVIG Market Analysis by Country
- 4.1 Global IVIG Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global IVIG Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global IVIG Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global IVIG Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global IVIG Sales and Market Share by Country (2020-2025)
- 4.2.2 Global IVIG Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States IVIG Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany IVIG Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan IVIG Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China IVIG Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France IVIG Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. IVIG Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea IVIG Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada IVIG Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy IVIG Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia IVIG Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico IVIG Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil IVIG Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India IVIG Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam IVIG Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand IVIG Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa IVIG Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global IVIG Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global IVIG Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global IVIG Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global IVIG Average Sales Price by Manufacturers (2021-2025)
- 5.2 IVIG Competitive Landscape Analysis and Market Dynamic
- 5.2.1 IVIG Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 IVIG Market Analysis by Type
- 6.1 Global IVIG Market Revenue Analysis by Type
- 6.1.1 Global IVIG Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global IVIG Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global IVIG Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global IVIG Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Baxter
- 7.1.1 Baxter Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Baxter IVIG Product Portfolio
- 7.1.3 Baxter IVIG Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 Grifols
- 7.2.1 Grifols Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Grifols IVIG Product Portfolio
- 7.2.3 Grifols IVIG Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 CSL
- 7.3.1 CSL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 CSL IVIG Product Portfolio
- 7.3.3 CSL IVIG Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 Octapharma
- 7.4.1 Octapharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 Octapharma IVIG Product Portfolio
- 7.4.3 Octapharma IVIG Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.5 Biotest
- 7.5.1 Biotest Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Biotest IVIG Product Portfolio
- 7.5.3 Biotest IVIG Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.6 Kedrion
- 7.6.1 Kedrion Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Kedrion IVIG Product Portfolio
- 7.6.3 Kedrion IVIG Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.7 Hualan Bio
- 7.7.1 Hualan Bio Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Hualan Bio IVIG Product Portfolio
- 7.7.3 Hualan Bio IVIG Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.8 CNBG
- 7.8.1 CNBG Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 CNBG IVIG Product Portfolio
- 7.8.3 CNBG IVIG Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.9 Shanghai RAAS
- 7.9.1 Shanghai RAAS Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Shanghai RAAS IVIG Product Portfolio
- 7.9.3 Shanghai RAAS IVIG Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.10 CBPO
- 7.10.1 CBPO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 CBPO IVIG Product Portfolio
- 7.10.3 CBPO IVIG Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.11 LFB Group
- 7.11.1 LFB Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 LFB Group IVIG Product Portfolio
- 7.11.3 LFB Group IVIG Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.12 BPL
- 7.12.1 BPL Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 BPL IVIG Product Portfolio
- 7.12.3 BPL IVIG Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.13 Sichuan Yuanda Shuyang
- 7.13.1 Sichuan Yuanda Shuyang Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Sichuan Yuanda Shuyang IVIG Product Portfolio
- 7.13.3 Sichuan Yuanda Shuyang IVIG Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 IVIG Industry Chain Analysis
- 8.2 IVIG Industry Upstream Supply Analysis
- 8.2.1 Upstream Key Raw Material Supply Analysis
- 8.2.2 Raw Material Suppliers and Contact Information
- 8.3 IVIG Product Downstream Application Analysis
- 8.3.1 Global IVIG Revenue Market Size by Application: 2024 & 2025 & 2032
- 8.3.2 Global IVIG Revenue and Forecast Analysis by Application (2020-2032)
- 8.3.3 Global IVIG Sales and Forecast Analysis by Application (2020-2032)
- 8.4 IVIG Typical Downstream Customers
- 8.5 IVIG Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.